Viewing nowRosamax Tablet (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Alvogen Korea Co., Ltd.

MFDS item code 200500963 · Notified 2005.02.01 · Insurance code 652600660
Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus and hypertension
This medication is used to stabilize blood pressure in patients with hypertension. Additionally, in patients with type 2 diabetes who have hypertension and kidney disease, it helps protect kidney function and slows the progression of kidney disease. Therefore, it is effective in improving kidney issues caused by hypertension and diabetes.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension, adults: The recommended initial and maintenance dose is losartan potassium 50 mg orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be given orally in 2 divided doses daily, or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). Older adults: No adjustment of the initial dose is necessary in older adults aged 75 years or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment: Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with reduced effective intravascular volume: An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced effective intravascular volume (e.g., patients receiving diuretic therapy) (see Precautions for Use). Patients with hepatic impairment: Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents 6 years of age and older who weigh 20 kg or more but less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50 mg once daily depending on the patient's blood pressure response. Children and adolescents 6 years of age and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Pediatric patients younger than 6 years: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. This medication should not be used in patients with severely impaired liver function or a history of hereditary angioedema. Patients with diabetes or moderate to severe kidney dysfunction should avoid taking this medication with certain other drugs. Elderly patients or those with high potassium levels or weakened liver function should use this medication with caution, ensuring that blood pressure does not drop too low. This medication can cause various side effects such as muscle cramps, dizziness, cough, gastrointestinal disturbances, and in severe cases, dangerous symptoms like angioedema or renal failure. If blood pressure drops suddenly or loss of consciousness occurs, immediate medical attention should be sought. It is important to regularly check kidney function and electrolyte levels through blood tests while taking this medication. There may be drug interactions, especially with potassium-sparing diuretics or potassium supplements, so caution should be exercised. Grapefruit juice may reduce the effectiveness of this medication, so it is advisable to avoid grapefruit juice while taking this medication. Women who are pregnant or breastfeeding should preferably avoid using this medication, and if it must be used, consultation with a healthcare professional is necessary. This medication is not to be used in children under the age of 6 or in children with severely impaired kidney function. Moreover, dizziness or drowsiness may occur when taking this medication, so caution is advised when driving or operating machinery. In case of overdose, symptoms such as hypotension and bradycardia may occur, and if symptoms arise, immediate notification to medical personnel is necessary. This medication should be kept out of reach of children and should not be transferred to another container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a closed container. It is also advisable to keep it in a dry place between 15°C and 30°C.
White oval film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Alvogen Korea Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.